Skip to main content
. Author manuscript; available in PMC: 2015 Sep 18.
Published in final edited form as: AIDS. 2015 Sep 10;29(14):1871–1882. doi: 10.1097/QAD.0000000000000790

Fig. 1. Distribution of CD4+ at the start of combination antiretroviral therapy by different outcomes.

Fig. 1

Fig. 1

Fig. 1

Stratified by: (a) adherence level over time; (b) achievement of suppression in 9 months after combination antiretroviral therapy initiation; (c) the emergence of resistance to any antiretroviral class during follow-up; (d) LTFU: lost to follow-up; (e) The emergence of an AIDS-defining illness during follow-up.